| 2013 |
The LIG3 gene encodes multiple DNA ligase polypeptides: the only mitochondrial DNA ligase (essential for that organelle), and nuclear DNA ligase IIIα which partners with XRCC1 in base excision repair (BER) and single-strand break repair. Nuclear LIG3α also functions in an alternative NHEJ (alt-NHEJ) pathway for DSB repair that is independent of its XRCC1 interaction, and can substitute for LIG1 in DNA replication when LIG1 is absent. |
Review synthesizing genetic, biochemical, and cell biological experiments across multiple studies |
Gene |
High |
24013086
|
| 2021 |
LIG3-XRCC1 complex serves as a backup system for Okazaki fragment ligation when LIG1 is absent. PARP1-HPF1-dependent ADP-ribosylation of histone H3 is required to recruit LIG3 onto chromatin for this backup ligation; depletion of PARP1 or HPF1 prevents LIG3 chromatin recruitment and Okazaki fragment joining in the absence of LIG1. |
Cell-free system from Xenopus egg extracts with immunodepletion of LIG1, PARP1, HPF1, and XRCC1; chromatin fractionation; ADP-ribosylation assays |
Nucleic acids research |
High |
33872376
|
| 2021 |
RAD52 inhibits single-strand break repair (SSBR) by reducing DNA-damage-promoted co-localization of XRCC1 and LIG3α at repair foci, via RAD52's high-affinity binding to single-stranded DNA (ssDNA) and poly(ADP-ribose) (PAR). |
Co-localization/imaging of XRCC1/LIG3α foci, RAD52 knockout/knockdown, camptothecin treatment, ssDNA and PAR binding assays, cell survival assays |
Cell reports |
Medium |
33440161
|
| 2018 |
MALAT1 lncRNA physically binds PARP1 and LIG3 and is a component of the alternative NHEJ (A-NHEJ) protein complex in multiple myeloma cells; degradation of MALAT1 by antisense oligonucleotides disrupts this complex, increases poly-ADP-ribosylation of nuclear proteins, and defects the DNA repair pathway leading to apoptosis. |
RNA-protein binding (co-immunoprecipitation of MALAT1 with PARP1/LIG3), antisense gapmer knockdown, in vitro and in vivo (xenograft) functional assays |
Leukemia |
Medium |
29632340
|
| 2015 |
c-MYC transcriptionally activates LIG3 and PARP1 expression in BCR-ABL1- and FLT3/ITD-driven leukemias. c-MYC negatively regulates miR-150 and miR-22, which in turn suppress LIG3 and PARP1, driving increased alt-NHEJ activity and genomic instability. |
c-MYC inhibition, miRNA overexpression (miR-150, miR-22), gene expression analysis in primary and cultured leukemia cells and patient samples, alt-NHEJ activity assays |
Molecular cancer research : MCR |
Medium |
25828893
|
| 2016 |
Telomere-internal double-strand breaks are repaired by a PARP1- and LIG3-dependent end-joining reaction consistent with alt-NHEJ or single-strand break repair, in addition to homologous recombination. |
FokI-induced DSBs at telomeres, genetic depletion of PARP1 and LIG3, telomere FISH and imaging, microhomology analysis |
Cell reports |
Medium |
27806302
|
| 2021 |
Biallelic loss-of-function variants in LIG3 cause mitochondrial DNA depletion (without multiple deletions), impair mtDNA maintenance, and result in mitochondrial dysfunction manifesting as a neurogastrointestinal encephalomyopathy syndrome. Patient-derived cells show reduced LIG3 protein and ligase activity; disruption of lig3 in zebrafish reproduces brain alterations and gut transit impairment. |
Whole exome sequencing, in vitro ligase activity assays in patient cells, zebrafish lig3 disruption model, mtDNA copy number quantification, muscle biopsy/COX staining |
Brain : a journal of neurology |
High |
33855352
|
| 2019 |
Sirt3 deacetylates LIG3 protein (along with other BER enzymes NEIL1, NEIL2, OGG1, MUTYH, APE1) in mitochondria; LIG3 is a substrate for Sirt3-mediated deacetylation, which modulates LIG3 activity in the mitochondrial BER pathway. |
Deacetylation assay with Sirt3 and BER substrates including LIG3 in colorectal cancer cells |
Polski przeglad chirurgiczny |
Low |
32312920
|
| 2025 |
Nuclear LIG3 is recruited to NHEJ complexes to facilitate end joining in the presence (but not catalytic activity) of LIG4. Mice lacking nuclear LIG3 and expressing catalytically inactive LIG4 die as embryos (lethal genetic interaction), whereas nuclear LIG3-deficient mice alone are viable, demonstrating that LIG3 substitutes for LIG4 catalytic activity in NHEJ when LIG4 is present as a structural scaffold. |
Mouse genetics: nuclear Lig3 knockout strain crossed to Lig4 catalytic-dead knock-in; timed mating/embryo resorption analysis; lymphocyte development assays |
Nucleic acids research |
High |
39673806
|
| 2025 |
LIG3 (with PARP1) performs an alternative Okazaki fragment maturation (OFM) process: when FEN1 demethylation by JMJD1B and subsequent LIG1 recruitment is disrupted, unprocessed 5' flaps trigger PARP1-dependent LIG3 recruitment to join incompletely processed Okazaki fragments. LIG3 has flap ligation activity in this context, supporting cell survival but causing duplications and mutations. |
Cell-based genetic disruption of JMJD1B and FEN1 R192Q mutation; PARP1 inhibition; PCNA binding assays; mutagenesis/sequencing |
bioRxivpreprint |
Medium |
41280084
|
| 2025 |
LIG3α exhibits an inability to ligate polβ dCTP:8-oxoG insertion products (error-free repair intermediates) at the final BER step, while it can seal nicks from polβ mutagenic dATP insertion opposite 8-oxoG. This demonstrates that the identity of the BER ligase critically determines repair outcome (mutagenic vs. error-free) at the ligation step. |
In vitro ligation assays with purified LIG1 and LIG3α on defined nick substrates containing polβ insertion products opposite 8-oxoG |
The Journal of biological chemistry |
Medium |
40286853
|
| 2025 |
YY1-Lig3-PARP1 form a complex in which Lig3 catalyzes DNA religation after YY1-mediated DNA looping to drive extrachromosomal DNA (ecDNA) biogenesis. PARylation-dependent acidic microenvironments mediated by the Lig3-YY1 complex promote Z-DNA formation, facilitating the fusion-religation process. |
Multi-layer perceptron modeling, imaging strategies in human cancer cells, clinical chip verification, PARP inhibitor functional assays |
Molecular cell |
Medium |
40769147
|
| 2018 |
M-LPH (Mpv17-like protein) knockout in human hepatoma cells reduces LIG3 protein levels in mitochondria (along with TFAM and OGG1), impairing mitochondrial BER capacity and increasing mtDNA damage. LIG3 protein stability in mitochondria is therefore dependent on M-LPH. |
CRISPR-Cas9 M-LPH knockout, Western blot and confocal immunofluorescence of mitochondrial LIG3 protein, mtDNA damage quantification by PCR and 8-OHdG measurement |
Oxidative medicine and cellular longevity |
Low |
30310528
|
| 2025 |
LIG3α binds less frequently to nick substrates (canonical A:T, mismatch G:T, and damaged 8-oxoG:A) than LIG1 but forms longer-lived complexes. Both ligases can bind gap DNA substrates with efficiency comparable to nicks; LIG1 forms more stable long-lived complexes on 1-nucleotide gaps, while LIG3α forms shorter-lived gap complexes. Both discriminate against larger gaps. |
Single-molecule total internal reflection fluorescence (TIRF) microscopy; in vitro ligation assays with purified LIG1 and LIG3α on defined substrates |
bioRxivpreprint |
Medium |
40666977
|
| 2025 |
LIG3 associates with telomeres in response to pyridostatin-induced G-quadruplex stabilization and participates in microhomology-mediated end joining (MMEJ) repair at telomeres. Depletion of MMEJ factors (including LIG3) enhances telomere loss in pyridostatin-treated cells. |
Telomeric protein composition analysis, MMEJ factor depletion, chemical inhibition, telomere loss assays in human cells treated with pyridostatin |
bioRxivpreprint |
Low |
41280084
|